论文信息 - Abstract P6-17-11: The small molecule inhibitor of HER2, tucatinib, has potent and highly selective activity in preclinical modes of HER2-driven cancer - 字舞流文

Abstract P6-17-11: The small molecule inhibitor of HER2, tucatinib, has potent and highly selective activity in preclinical modes of HER2-driven cancer

S. Hurvitz | D. Slamon | Tong Luo | D. Conklin | N. O’Brien | Raul Ayala | Shawnt Issakhanian | S. Salgar | M. McDermott